GO:0032929 negative regulation of superoxide anion generation: Regulatory Pathway, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0032929 describes any process that stops, prevents, or reduces the enzymatic generation of superoxide anion by a cell.
• Superoxide anion is a primary reactive oxygen species (ROS) produced by enzymes such as NADPH oxidases (NOX), xanthine oxidase, and the mitochondrial electron transport chain.
• Negative regulation occurs at multiple levels, including post-translational modifications (e.g., phosphorylation of eNOS), protein-protein interactions (e.g., SHP-1), and metabolic modulation (e.g., PFK-1 inhibition).
• Dysregulated superoxide generation is implicated in cardiovascular diseases, cancer, and inflammatory disorders, making this process a therapeutic target.
• Key negative regulators include SHP-1, eNOS (when phosphorylated), and prohibitin, which modulate superoxide production in endothelial cells, macrophages, and sperm.
• CRISPR-based models (knockout, point mutation, knock-in, overexpression) enable precise dissection of negative regulatory mechanisms in relevant cell types.
Description
Superoxide anion (O2•−) is a reactive oxygen species (ROS) generated by enzymatic systems such as NADPH oxidases (NOX), the mitochondrial electron transport chain, and xanthine oxidase. While superoxide plays essential roles in host defense and cell signaling, its overproduction leads to oxidative stress, tissue damage, and disease. The Gene Ontology term GO:0032929, negative regulation of superoxide anion generation, encompasses any process that stops, prevents, or reduces the frequency, rate, or extent of enzymatic superoxide production by a cell. This regulation is critical for maintaining redox homeostasis and preventing pathological conditions. Researchers study this process to understand how cells balance ROS production and to identify therapeutic targets for diseases driven by oxidative stress.
negative regulation of superoxide anion generation At A Glance
| GO ID | GO:0032929 |
|---|---|
| GO term | negative regulation of superoxide anion generation |
| Ontology | biological_process |
| Synonym | down regulation of superoxide release, down-regulation of superoxide release, downregulation of superoxide release, inhibition of superoxide release, negative regulation of superoxide release |
| Major function | Suppression of enzymatic superoxide anion production to maintain redox balance and prevent oxidative damage |
| Regulatory inputs | Phosphorylation, protein-protein interactions, metabolic signals, and small-molecule inhibitors |
| Key enzymes regulated | NADPH oxidases (NOX1-5), endothelial nitric-oxide synthase (eNOS), mitochondrial complex I |
| Associated diseases | Cardiovascular disease, cancer, inflammation, male infertility |
What Is GO:0032929?
GO:0032929 is defined as any process that stops, prevents, or reduces the frequency, rate or extent of enzymatic generation of superoxide by a cell. It includes mechanisms that downregulate the activity or expression of superoxide-producing enzymes, such as NADPH oxidases, or that enhance the activity of antioxidant systems that remove superoxide. This term is a biological process and is synonymous with down regulation of superoxide release, down-regulation of superoxide release, downregulation of superoxide release, inhibition of superoxide release, and negative regulation of superoxide release.
Why Is negative regulation of superoxide anion generation Important in Cell Biology?
Negative regulation of superoxide anion generation is essential for cellular redox homeostasis. Excessive superoxide production contributes to the pathogenesis of numerous diseases, including hypertension, atherosclerosis, cancer, and neurodegenerative disorders. Understanding the mechanisms that restrain superoxide generation can reveal new therapeutic targets and biomarkers. For example, the tyrosine phosphatase SHP-1 negatively regulates endothelial superoxide formation, and its dysfunction is linked to vascular oxidative stress. Similarly, phosphorylation of eNOS modulates its ability to generate superoxide versus nitric oxide, impacting endothelial function. Thus, studying GO:0032929 provides insights into fundamental cell biology and disease mechanisms.
• Maintains redox balance by preventing excessive superoxide accumulation.
• Protects against oxidative damage to lipids, proteins, and DNA.
• Regulates vascular tone and endothelial function through eNOS modulation.
• Influences inflammatory signaling in macrophages and immune cells.
• Impacts mitochondrial function and sperm physiology via complex I regulation.
• Modulates cancer cell metabolism and survival through PFK-1 inhibition.
• Provides therapeutic targets for cardiovascular diseases and cancer.
• Helps understand NOX5 regulation in calcium signaling and disease.
• Guides development of small-molecule inhibitors for superoxide suppression.
• Essential for interpreting CRISPR screens targeting ROS pathways.
What Happens During negative regulation of superoxide anion generation?
Inhibition of Superoxide-Producing Enzymes
In simple terms: Cells can turn off the enzymes that make superoxide.
Negative regulation often involves direct inhibition of enzymes such as NADPH oxidases (NOX) or xanthine oxidase. For instance, SHP-1, a tyrosine phosphatase, negatively regulates endothelial superoxide formation by dephosphorylating key signaling proteins. Similarly, phosphorylation of endothelial nitric-oxide synthase (eNOS) can shift its activity from nitric oxide production to superoxide generation, and specific phosphorylation events can suppress superoxide output. Small-molecule inhibitors of 6-phosphofructo-1-kinase (PFK-1) simultaneously suppress lactate and superoxide generation in cancer cells, linking glycolysis to ROS regulation.
Post-Translational Modifications of Regulatory Proteins
In simple terms: Chemical tags on proteins can change how much superoxide is made.
Phosphorylation and other post-translational modifications modulate the activity of superoxide-generating enzymes. For example, phosphorylation of eNOS at specific residues regulates superoxide generation from the enzyme. The reductase domain of eNOS also contributes to superoxide production, and its regulation involves conformational changes. In bovine alveolar macrophages, modulators of signal transduction such as lipopolysaccharide and serum proteins influence superoxide anion generation, highlighting the role of signaling cascades.
Metabolic and Mitochondrial Control
In simple terms: Cell metabolism and mitochondria can dial down superoxide production.
Mitochondrial complex I is a major source of superoxide, and proteins like prohibitin are involved in its generation in human sperm. Negative regulation can occur through metabolic shifts; for instance, inhibition of PFK-1 reduces superoxide in cancer cells, suggesting that glycolytic flux modulates ROS. Additionally, sulfide negatively regulates autophagy independent of ROS, indicating crosstalk between redox and degradative pathways.
Regulation of NOX5 and Calcium Signaling
In simple terms: Calcium signals can control a specific superoxide-making enzyme called NOX5.
NADPH oxidase 5 (NOX5) is unique among NOX family members as it is activated by calcium. Its structure, regulation, and physiological functions have been reviewed, highlighting that negative regulation of NOX5 may involve calcium-binding proteins or phosphorylation. Understanding how NOX5 activity is restrained is important for diseases where calcium signaling is dysregulated.
Key Genes Involved in GO:0032929 negative regulation of superoxide anion generation
The following genes and proteins are central to the negative regulation of superoxide anion generation, based on published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| SHP-1 (PTPN6) | Tyrosine phosphatase that negatively regulates endothelial superoxide formation | Vascular oxidative stress, endothelial dysfunction |
| eNOS (NOS3) | Nitric oxide synthase; phosphorylation regulates superoxide generation | Endothelial function, cardiovascular disease |
| NOX5 | Calcium-activated NADPH oxidase; target of negative regulation | Calcium signaling, cancer, cardiovascular disease |
| Prohibitin (PHB) | Mitochondrial protein involved in superoxide generation at complex I | Sperm physiology, mitochondrial function |
| PFK-1 (PFKM) | Glycolytic enzyme; its inhibition suppresses superoxide generation | Cancer metabolism, ROS regulation |
| NOX1 | NADPH oxidase isoform; regulated by various negative feedback mechanisms | Inflammation, cancer |
| NOX2 (CYBB) | Phagocyte NADPH oxidase; negative regulation controls respiratory burst | Host defense, autoimmunity |
| NOX4 | Constitutively active NADPH oxidase; regulated by expression and localization | Fibrosis, cancer |
| Xanthine oxidase (XDH) | Produces superoxide during purine metabolism; negatively regulated by inhibitors | Gout, ischemia-reperfusion |
| Mitochondrial complex I (NDUFS1 etc.) | Major site of superoxide generation; regulated by prohibitin and others | Mitochondrial diseases, aging |
| SOD1 (Cu/ZnSOD) | Superoxide dismutase; not a negative regulator per se but removes superoxide | Amyotrophic lateral sclerosis, redox balance |
| SOD2 (MnSOD) | Mitochondrial superoxide dismutase; removes superoxide | Cancer, neurodegeneration |
| Catalase (CAT) | Detoxifies hydrogen peroxide derived from superoxide | Inflammation, aging |
| Glutathione peroxidase (GPX1) | Reduces hydrogen peroxide and lipid peroxides | Cardiovascular disease |
| Nrf2 (NFE2L2) | Transcription factor that upregulates antioxidant genes | Oxidative stress response |
| Keap1 (KEAP1) | Negative regulator of Nrf2; indirectly affects superoxide levels | Cancer, chemoprevention |
| AMPK (PRKAA1) | Energy sensor that can suppress ROS production | Metabolic disorders, cancer |
| Sirtuin 1 (SIRT1) | Deacetylase that reduces oxidative stress | Aging, cardiovascular disease |
How Is negative regulation of superoxide anion generation Regulated?
The negative regulation of superoxide anion generation is itself regulated at multiple levels. Transcriptional control of antioxidant enzymes (e.g., SOD1, SOD2, catalase) via Nrf2/Keap1 influences superoxide levels. Post-translational modifications, such as phosphorylation of eNOS by Akt or AMPK, can switch the enzyme from superoxide-generating to nitric oxide-producing. Protein-protein interactions, such as SHP-1 binding to signaling complexes, provide rapid inhibition. Metabolic signals, including glycolytic flux and PFK-1 activity, modulate superoxide production in cancer cells. Additionally, calcium signaling regulates NOX5 activity, and its negative regulation may involve calcium-binding proteins. These layers ensure fine-tuned control of ROS for cellular homeostasis.
negative regulation of superoxide anion generation and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| SHP-1 (PTPN6) | Vascular oxidative stress, endothelial dysfunction | Endothelial cell KO and overexpression |
| eNOS (NOS3) | Hypertension, atherosclerosis | Point mutation at phosphorylation sites |
| NOX5 | Cancer, cardiovascular disease | Knock-in of calcium-binding mutants |
| PFK-1 (PFKM) | Cancer metabolism | Small-molecule inhibitor treatment and KO |
| Prohibitin (PHB) | Male infertility, mitochondrial disease | Sperm-specific KO and knock-in |
Cardiovascular Disease
Excessive superoxide production contributes to endothelial dysfunction, hypertension, and atherosclerosis. SHP-1 negatively regulates endothelial superoxide formation, and its reduced activity is associated with vascular oxidative stress. Phosphorylation of eNOS that favors superoxide generation over nitric oxide is linked to cardiovascular pathology. Targeting these negative regulatory pathways could restore endothelial function.
Cancer
Cancer cells often exhibit altered ROS levels. Inhibition of PFK-1 suppresses superoxide generation in cancer cells, linking glycolysis to redox regulation. NOX5 is implicated in cancer cell proliferation and survival, and its negative regulation may offer therapeutic opportunities. Understanding how superoxide is restrained in cancer could lead to novel treatments.
Inflammatory and Immune Disorders
In macrophages, superoxide generation is part of the respiratory burst essential for pathogen killing. Negative regulation prevents excessive tissue damage. Bacterial lipopolysaccharide and serum proteins modulate superoxide anion generation in bovine alveolar macrophages, highlighting the importance of tight control. Dysregulation can lead to chronic inflammation.
Male Infertility and Mitochondrial Dysfunction
Prohibitin is involved in mitochondrial superoxide generation at complex I in human sperm, and its dysregulation may affect sperm function and fertility. Mitochondrial superoxide is also linked to aging and neurodegenerative diseases, where negative regulatory mechanisms are critical.
From negative regulation of superoxide anion generation-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does SHP-1 negatively regulate endothelial superoxide? | SHP-1 knockout endothelial cells |
| How does eNOS phosphorylation affect superoxide generation? | Point mutations at phosphorylation sites (e.g., S1177A) |
| What is the role of NOX5 calcium binding in superoxide production? | Knock-in of calcium-binding domain mutants |
| Can PFK-1 inhibition suppress superoxide in cancer cells? | PFK-1 knockout or overexpression in cancer cell lines |
| Is prohibitin required for mitochondrial superoxide generation? | Prohibitin knockout in sperm cells |
| How does LPS modulate superoxide in macrophages? | Macrophage cell line with TLR4 knockout |
How to Study the negative regulation of superoxide anion generation Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Dihydroethidium (DHE) staining | Superoxide levels in cells | Endothelial cells treated with SHP-1 modulators |
| Lucigenin chemiluminescence | Superoxide production in cell lysates | Macrophage respiratory burst |
| Phospho-specific Western blot | Phosphorylation status of eNOS | eNOS regulation by Akt/AMPK |
| CRISPR knockout | Gene function loss | SHP-1 KO in endothelial cells |
| CRISPR point mutation | Specific amino acid changes | eNOS phosphorylation site mutants |
| CRISPR knock-in | Tagged or mutant protein expression | NOX5 calcium-binding mutants |
| Seahorse assay | Glycolytic and oxidative metabolism | PFK-1 inhibition in cancer cells |
| Electron spin resonance | Direct superoxide radical detection | Mitochondrial complex I studies |
Measuring Superoxide Generation
Superoxide levels can be quantified using chemiluminescence (e.g., lucigenin), fluorescence (e.g., dihydroethidium), or electron spin resonance. These methods are used to assess the impact of negative regulators in cell models.
Genetic Manipulation with CRISPR
CRISPR-Cas9 knockout, point mutation, knock-in, and overexpression are used to dissect the function of genes involved in negative regulation. For example, knocking out SHP-1 increases endothelial superoxide, confirming its negative regulatory role.
Phosphorylation Analysis
Western blotting with phospho-specific antibodies detects changes in eNOS phosphorylation at residues such as Ser1177 and Thr495, which regulate superoxide versus nitric oxide production.
Metabolic Assays
Seahorse extracellular flux analysis and lactate measurements assess glycolytic flux, which is linked to superoxide generation. PFK-1 inhibitors are used to test effects on superoxide.
How CRISPR Can Be Used to Study GO:0032929 negative regulation of superoxide anion generation
Knockout
CRISPR knockout of negative regulators such as SHP-1 or PFK-1 leads to increased superoxide generation, confirming their inhibitory roles. This approach is used in endothelial cells and cancer cell lines.
Point Mutation
Point mutations at phosphorylation sites of eNOS (e.g., S1177A) prevent negative regulation, resulting in enhanced superoxide production. This helps map regulatory phosphosites.
Knock-in
Knock-in of mutant NOX5 with altered calcium-binding sites allows study of calcium-dependent regulation of superoxide generation.
Overexpression
Overexpression of negative regulators like SHP-1 or SOD1 reduces superoxide levels, providing gain-of-function evidence. This is useful for validating therapeutic targets.
How EDITGENE Supports negative regulation of superoxide anion generation Research
Researchers studying negative regulation of superoxide anion generation-related genes often need to determine whether a candidate gene is causally involved in suppressing superoxide production or is merely correlated. This requires precise genetic models that can knockout, mutate, knock-in, or overexpress the gene of interest in relevant cell types.
Contact EDITGENE today to design your custom CRISPR model for negative regulation of superoxide anion generation research.
Frequently Asked Questions About negative regulation of superoxide anion generation
What is GO:0032929?
GO:0032929 is the Gene Ontology term for negative regulation of superoxide anion generation, describing any process that stops, prevents, or reduces the enzymatic production of superoxide by a cell.
What genes are involved in negative regulation of superoxide anion generation?
Key genes include SHP-1 (PTPN6), eNOS (NOS3), PFK-1 (PFKM), prohibitin (PHB), and NOX5, among others.
How is superoxide anion generation negatively regulated?
It is regulated through post-translational modifications (e.g., phosphorylation), protein-protein interactions (e.g., SHP-1), metabolic signals (e.g., PFK-1 inhibition), and calcium signaling.
What diseases are associated with dysregulated superoxide anion generation?
Cardiovascular disease, cancer, inflammatory disorders, and male infertility are linked to impaired negative regulation of superoxide.
Which enzyme is a major source of superoxide in endothelial cells?
NADPH oxidases (NOX) and eNOS (when uncoupled) are major sources; SHP-1 negatively regulates endothelial superoxide formation.
How does phosphorylation affect eNOS superoxide generation?
Phosphorylation at specific residues can switch eNOS from nitric oxide production to superoxide generation, and certain phosphosites are inhibitory.
What is the role of PFK-1 in superoxide regulation?
PFK-1 inhibition simultaneously suppresses lactate and superoxide generation in cancer cells, linking glycolysis to ROS control.
Can CRISPR be used to study negative regulation of superoxide?
Yes, CRISPR knockout, point mutation, knock-in, and overexpression models are powerful tools to dissect gene function in this pathway.
What is the function of NOX5 in superoxide generation?
NOX5 is a calcium-activated NADPH oxidase that produces superoxide; its regulation involves calcium binding and phosphorylation.
How does prohibitin relate to superoxide in sperm?
Prohibitin is involved in mitochondrial superoxide generation at complex I in human sperm, affecting sperm function.
Conclusion
GO:0032929, negative regulation of superoxide anion generation, is a critical biological process that maintains redox homeostasis by restraining enzymatic superoxide production. Key regulators such as SHP-1, eNOS, PFK-1, and NOX5 modulate this process through diverse mechanisms including phosphorylation, protein interactions, and metabolic control. Dysregulation contributes to cardiovascular disease, cancer, and infertility, making it a rich area for therapeutic targeting. Advances in CRISPR-based models and screening technologies are accelerating the discovery of new regulatory nodes and drug candidates.
References
- 1. Jian ZJ et al.. 1995. Regulation of superoxide anion generation in bovine alveolar macrophages by bacterial lipopolysaccharide, serum proteins, and modulators of signal transduction.. Inflammation 19(6):637-50 PMID: 8595931
- 2. Laureano-Marín AM et al.. 2016. Negative Regulation of Autophagy by Sulfide Is Independent of Reactive Oxygen Species.. Plant Physiol 171(2):1378-91 PMID: 27208225
- 3. Chen CA et al.. 2008. Phosphorylation of endothelial nitric-oxide synthase regulates superoxide generation from the enzyme.. J Biol Chem 283(40):27038-47 PMID: 18622039
- 4. Chai RR et al.. 2017. Prohibitin involvement in the generation of mitochondrial superoxide at complex I in human sperm.. J Cell Mol Med 21(1):121-129 PMID: 27558591
- 5. Peng H et al.. 2015. The Characteristics and Regulatory Mechanisms of Superoxide Generation from eNOS Reductase Domain.. PLoS One 10(10):e0140365 PMID: 26465144
- 6. García JG et al.. 2023. Structure, regulation, and physiological functions of NADPH oxidase 5 (NOX5).. J Physiol Biochem 79(2):383-395 PMID: 36905456
- 7. Krötz F et al.. 2005. The tyrosine phosphatase, SHP-1, is a negative regulator of endothelial superoxide formation.. J Am Coll Cardiol 45(10):1700-6 PMID: 15893190
- 8. Lešnik S et al.. 2025. Small-molecule inhibitors of 6-phosphofructo-1-kinase simultaneously suppress lactate and superoxide generation in cancer cells.. PLoS One 20(5):e0321998 PMID: 40397908
